207 related articles for article (PubMed ID: 27261776)
1. Activation of proteinase 3 contributes to Non-alcoholic Fatty Liver Disease (NAFLD) and insulin resistance.
Toonen EJ; Mirea AM; Tack CJ; Stienstra R; Ballak DB; van Diepen JA; Hijmans A; Chavakis T; Dokter WH; Pham CT; Netea MG; Dinarello CA; Joosten LA
Mol Med; 2016 May; 22():202-14. PubMed ID: 27261776
[TBL] [Abstract][Full Text] [Related]
2. Mice Deficient in the IL-1β Activation Genes Prtn3, Elane, and Casp1 Are Protected Against the Development of Obesity-Induced NAFLD.
Mirea AM; Stienstra R; Kanneganti TD; Tack CJ; Chavakis T; Toonen EJM; Joosten LAB
Inflammation; 2020 Jun; 43(3):1054-1064. PubMed ID: 32002713
[TBL] [Abstract][Full Text] [Related]
3. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.
Cheng X; Yamauchi J; Lee S; Zhang T; Gong Z; Muzumdar R; Qu S; Dong HH
J Biol Chem; 2017 Mar; 292(9):3692-3705. PubMed ID: 28115523
[TBL] [Abstract][Full Text] [Related]
4. Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes.
Mirea AM; Toonen EJM; van den Munckhof I; Munsterman ID; Tjwa ETTL; Jaeger M; Oosting M; Schraa K; Rutten JHW; van der Graaf M; Riksen NP; de Graaf J; Netea MG; Tack CJ; Chavakis T; Joosten LAB
Mol Med; 2019 May; 25(1):16. PubMed ID: 31046673
[TBL] [Abstract][Full Text] [Related]
5. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
Liu X; Chen S; Zhang L
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319
[TBL] [Abstract][Full Text] [Related]
6. Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD.
Luo Y; Burrington CM; Graff EC; Zhang J; Judd RL; Suksaranjit P; Kaewpoowat Q; Davenport SK; O'Neill AM; Greene MW
Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E418-39. PubMed ID: 26670487
[TBL] [Abstract][Full Text] [Related]
7. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
Fu D; Cui H; Zhang Y
Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta.
Joosten LA; Netea MG; Fantuzzi G; Koenders MI; Helsen MM; Sparrer H; Pham CT; van der Meer JW; Dinarello CA; van den Berg WB
Arthritis Rheum; 2009 Dec; 60(12):3651-62. PubMed ID: 19950280
[TBL] [Abstract][Full Text] [Related]
9. Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters - an animal model of life style intervention in NAFLD.
Gehrke N; Biedenbach J; Huber Y; Straub BK; Galle PR; Simon P; Schattenberg JM
Sci Rep; 2019 Mar; 9(1):4007. PubMed ID: 30850619
[TBL] [Abstract][Full Text] [Related]
10. Hepatic STAMP2 alleviates high fat diet-induced hepatic steatosis and insulin resistance.
Kim HY; Park SY; Lee MH; Rho JH; Oh YJ; Jung HU; Yoo SH; Jeong NY; Lee HJ; Suh S; Seo SY; Cheong J; Jeong JS; Yoo YH
J Hepatol; 2015 Aug; 63(2):477-85. PubMed ID: 25646886
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil Proteases Promote Experimental Abdominal Aortic Aneurysm via Extracellular Trap Release and Plasmacytoid Dendritic Cell Activation.
Yan H; Zhou HF; Akk A; Hu Y; Springer LE; Ennis TL; Pham CTN
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1660-1669. PubMed ID: 27283739
[TBL] [Abstract][Full Text] [Related]
12. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
14. Sake lees extract improves hepatic lipid accumulation in high fat diet-fed mice.
Kubo H; Hoshi M; Matsumoto T; Irie M; Oura S; Tsutsumi H; Hata Y; Yamamoto Y; Saito K
Lipids Health Dis; 2017 Jun; 16(1):106. PubMed ID: 28578672
[TBL] [Abstract][Full Text] [Related]
15. α1-Antitrypsin A treatment attenuates neutrophil elastase accumulation and enhances insulin sensitivity in adipose tissue of mice fed a high-fat diet.
D'Souza RF; Masson SWC; Woodhead JST; James SL; MacRae C; Hedges CP; Merry TL
Am J Physiol Endocrinol Metab; 2021 Oct; 321(4):E560-E570. PubMed ID: 34486403
[TBL] [Abstract][Full Text] [Related]
16. FBXW7 suppresses HMGB1-mediated innate immune signaling to attenuate hepatic inflammation and insulin resistance in a mouse model of nonalcoholic fatty liver disease.
Zhang C; Chen F; Feng L; Shan Q; Zheng GH; Wang YJ; Lu J; Fan SH; Sun CH; Wu DM; Li MQ; Hu B; Wang QQ; Zhang ZF; Zheng YL
Mol Med; 2019 Jun; 25(1):29. PubMed ID: 31215394
[TBL] [Abstract][Full Text] [Related]
17. Short-term strength training reduces gluconeogenesis and NAFLD in obese mice.
Pereira RM; Rodrigues KCDC; Anaruma CP; Sant'Ana MR; de Campos TDP; Gaspar RS; Canciglieri RDS; de Melo DG; Mekary RA; da Silva ASR; Cintra DE; Ropelle ER; Pauli JR; de Moura LP
J Endocrinol; 2019 Apr; 241(1):59-70. PubMed ID: 30878016
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice.
Cartland SP; Harith HH; Genner SW; Dang L; Cogger VC; Vellozzi M; Di Bartolo BA; Thomas SR; Adams LA; Kavurma MM
Sci Rep; 2017 May; 7(1):1898. PubMed ID: 28507343
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation.
Tang Y; Cao G; Min X; Wang T; Sun S; Du X; Zhang W
J Physiol Biochem; 2018 Nov; 74(4):503-510. PubMed ID: 30019185
[TBL] [Abstract][Full Text] [Related]
20. Impact of glycosylphosphatidylinositol-specific phospholipase D on hepatic diacylglycerol accumulation, steatosis, and insulin resistance in diet-induced obesity.
Masuda S; Fujishima Y; Maeda N; Tsugawa-Shimizu Y; Nakamura Y; Tanaka Y; Obata Y; Fukuda S; Nagao H; Kita S; Nishizawa H; Shimomura I
Am J Physiol Endocrinol Metab; 2019 Feb; 316(2):E239-E250. PubMed ID: 30457913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
